Topotecan in small cell lung cancer: first or second line?
Campling
Barbara
B
University of Pennsylvania, Philadelphia, 19104, USA. camplinb@mail.med.upenn.edu
D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D015203:Reproducibility of Results; D019772:Topotecan / Q000627:therapeutic use* / Q000633:toxicity
D000970:Antineoplastic Agents; D019772:Topotecan